Clinical Trials Browser

Phase 2 × Etoricoxib × Clear all

NCT00095017 2022-02-16

Safety and Efficacy of an Investigational Drug Versus Placebo in the Treatment of Cancer Pain (0663-083)

Phase 2 Withdrawn

Bone Neoplasms

NCT04565600 2022-02-14

Prevention of Taxane-associated Acute Pain Syndrome With Etoricoxib

Phase 2 Completed

Breast Neoplasms, Peripheral Nervous System Diseases, Somatoform Disorders

NCT02456363 2015-05-28

Anti-Tumor Necrosis Factor Therapy In Patients With Ankylosing Spondylitis

Phase 2 Unknown

Spondylitis, Ankylosing